1. Home
  2. DKL vs INDV Comparison

DKL vs INDV Comparison

Compare DKL & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DKL
  • INDV
  • Stock Information
  • Founded
  • DKL 2012
  • INDV 1994
  • Country
  • DKL United States
  • INDV United States
  • Employees
  • DKL N/A
  • INDV N/A
  • Industry
  • DKL Natural Gas Distribution
  • INDV Biotechnology: Pharmaceutical Preparations
  • Sector
  • DKL Energy
  • INDV Health Care
  • Exchange
  • DKL Nasdaq
  • INDV Nasdaq
  • Market Cap
  • DKL 2.3B
  • INDV 1.9B
  • IPO Year
  • DKL N/A
  • INDV N/A
  • Fundamental
  • Price
  • DKL $43.27
  • INDV $24.32
  • Analyst Decision
  • DKL Buy
  • INDV Strong Buy
  • Analyst Count
  • DKL 4
  • INDV 4
  • Target Price
  • DKL $44.25
  • INDV $20.75
  • AVG Volume (30 Days)
  • DKL 94.9K
  • INDV 4.3M
  • Earning Date
  • DKL 08-06-2025
  • INDV 07-31-2025
  • Dividend Yield
  • DKL 10.36%
  • INDV N/A
  • EPS Growth
  • DKL 1.28
  • INDV N/A
  • EPS
  • DKL 2.96
  • INDV 0.42
  • Revenue
  • DKL $920,213,000.00
  • INDV $1,173,000,000.00
  • Revenue This Year
  • DKL $21.09
  • INDV N/A
  • Revenue Next Year
  • DKL N/A
  • INDV $3.00
  • P/E Ratio
  • DKL $14.64
  • INDV $58.42
  • Revenue Growth
  • DKL N/A
  • INDV 2.27
  • 52 Week Low
  • DKL $34.59
  • INDV $7.33
  • 52 Week High
  • DKL $48.00
  • INDV $24.64
  • Technical
  • Relative Strength Index (RSI)
  • DKL 46.83
  • INDV 90.72
  • Support Level
  • DKL $42.67
  • INDV $23.08
  • Resistance Level
  • DKL $43.58
  • INDV $24.24
  • Average True Range (ATR)
  • DKL 1.08
  • INDV 0.70
  • MACD
  • DKL -0.11
  • INDV 0.01
  • Stochastic Oscillator
  • DKL 38.27
  • INDV 90.80

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Share on Social Networks: